NYSEIndustrialsIndustrial - MachinerySnapshot 2026-08-31
Reading IEX? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Intact: The reason to own it still holds.
IDEX grows revenue about 3% to 4% yearly. It raised full-year EPS guidance to $8.35-$8.55. The company has beaten EPS estimates recently by 13% and 3%. It buys back shares, supporting shareholder returns.
Revenue growth is soft and volatile, with recent declines in some quarters. Net income fell slightly in late 2025. The sector faces headwinds that could pressure margins and growth.
The price is about 11% above our fair value near $201, reflecting roughly 5% revenue growth. Our fair value is 20% below the Street median, so the market partly prices in stronger growth than we expect.
Breaks if: EPS misses in more than 1 quarter out of 4
Breaks if: EPS guidance falls below $8.35 for FY26
Breaks if: Organic sales growth falls below 3% YoY in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable growth company with a focus on increasing organic sales and returning capital to shareholders. The current thesis state is intact, supported by recent earnings beats and a commitment to growth.
The market seems to have priced in a justified valuation, with a low expectations gap suggesting that investors are not overly optimistic. The valuation is aligned with peers, indicating a moderate premium.
Fundamentals are likely to remain stable, with management focused on organic sales growth and raising earnings guidance. The near-term risk of missing expectations is low, though there is a history of deeper misses that warrants caution.
The thesis hinges on the performance of sector bellwethers like GEV, PH, and TT. If these companies continue to perform well, it could support IEX's growth. Conversely, any negative guidance from these peers could impact IEX's momentum.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: No buyback authorization or buyback program halted
Overall, IEX appears to be on a solid path with stable management and growth priorities. Not investment advice.
